Article
Applying personalized medicine to adult severe asthma.
Allergy and asthma proceedings - 1 Jan 2021
Tiotiu Angelica
Abstract excerpt
Background: Severe asthma is a heterogeneous disease that consists of various phenotypes driven by different pathways. Associated with significant morbidity, an important negative impact on the quality of life of patients, and increased health care costs, severe asthma represents a challenge for the clinician. With the introduction of various antibodies that target type 2 inflammation (T2) pathways, severe asthma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
